Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Breakthrough T1D takes next step in raising awareness of early detection, with support from Sanofi
This announcement marks the beginning of a wider alliance of partners committed to helping every person who develops T1D begin their journey with the best possible support.
Early detection will reduce the number of diagnoses that occur during life-threatening diabetic ketoacidosis (DKA), offering a safer and more stable starting point for people who develop the condition. Knowing that you will develop symptomatic T1D in advance provides valuable time for people to learn how to manage the condition, explore treatment options and prepare both emotionally and practically.
At the same time, type 1 diabetes is beginning to shift from a condition that can only be treated after symptoms appear to one that might be delayed. One therapy is currently awaiting regulatory approval, with many more in clinical trials
Early detection is opening the door to a future where living with T1D begins not in crisis, but with knowledge, preparation and support. Yet currently, there is no national early detection programme, and most people can only access screening through clinical studies. Our shared goal is to establish a comprehensive national screening programme by 2030.
As part of this programme of work, we’ll be developing a white paper on the benefits of early detection and a set of educational resources to help people understand how T1D develops. These materials will focus on the key signs and symptoms to look out for with a specific focus on the 4Ts which are tired, thirsty, thinner and going to the toilet more frequently. We’ll also provide guidance on how to access screening programmes and get tested once symptoms begin.
Karen Addington, CEO of Breakthrough T1D says: “Early detection of T1D offers something we’ve never had before – time to prepare, and options to act. Raising awareness. not only of screening but of signs and symptoms, is critical to ensure that more families can avoid the trauma of a diagnosis in crisis. Early detection provides a more hopeful beginning to life with T1D.”
We’re grateful for Sanofi’s support and look forward to welcoming more partners who share our commitment to changing what a T1D diagnosis looks and feels like, enabling earlier detection, better preparation and reducing the distress of emergency hospital visits.
Sanofi have provided financial support for raising awareness of the benefits of early detection of T1D but have no input or involvement into the content or output of our work.
Find out about the global research we're funding to find cures and better treatments for T1D.
Get information and advice about living well with type 1.
Join our mission to find cures for T1D and, until then, make life better for people living with it.
You may have heard of a new feature called ‘CamAPS Liberty’, which will soon be available on the CamAPS FX app. This ‘fully closed-loop’ (FCL) mode, when activated; will allow users to remove the need to count carbohydrates before a meal. But what does this mean for people with type 1 diabetes (T1D), and how close are we to removing meal announcement altogether? Here is what we know…
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
